JP Morgan Chase
MESO

JP Morgan Chase’s Mesoblast MESO Stock Holding History

JP Morgan Chase’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-50,000
Closed -$1.92M – 5814
2020
Q3 		$1.92M Buy
+50,000
New +$1.57M ﹤0.01% 3263

Other funds holding MESO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
PM
Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

JP Morgan Chase's MESO Position: Q1 2026 in Review

JP Morgan Chase increased its Mesoblast (MESO) stake by 2.8% in Q1 2026, buying an estimated $1.48K and bringing the position to 3,289 shares worth $47.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6223.

JP Morgan Chase first reported a position in MESO in Q1 2018 and has held it in 10 quarters since. The position peaked at $1.92M in Q3 2020. 69 funds tracked by Wall St. Rank hold MESO as of Q1 2026.

  • JP Morgan Chase held 3,289 shares of Mesoblast worth $47.3K as of Q1 2026.
  • JP Morgan Chase bought 89 Mesoblast shares in Q1 2026, an estimated $1.48K.
  • Mesoblast made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6223 holding.
  • JP Morgan Chase first reported a position in Mesoblast in Q1 2018 and has held it in 10 quarters since.
  • JP Morgan Chase's Mesoblast position peaked at $1.92M in Q3 2020.
  • 69 funds tracked by Wall St. Rank held Mesoblast as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.